Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...
Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback